Bayer Vardenafil Launch To Use Men’s Health Reps; Cipro To Be Detailed Initially
Executive Summary
Bayer is creating a 100- to 150-rep men's health specialty sales force in anticipation of FDA approval of its erectile dysfunction product vardenafil
You may also be interested in...
PDI/Bayer Detailing Focuses On Cipro, Avelox After Baycol Withdrawal
PDI and Bayer are discussing which product will replace Bayer's withdrawn cholesterol-lowering agent Baycol in their contract sales agreement
Watson Oxytrol Launch Planned For Mid-2002 As Firm Shifts Focus To Brands
Watson plans to use a marketing partner or contract sales organization to launch its overactive bladder transdermal patch Oxytrol (oxybutynin)
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011